Diversicare Announces 2019 Second Quarter Results

NEXT STORY
Bellicum Pharmaceuticals Reports Second Quarter 2019 Financial Results and Provides Operational Update
PREV STORY
Entasis Therapeutics Appoints Dr. Howard Mayer to Board of Directors
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Allarity Therapeutics Initiates Phase 2 Trial of IXEMPRA® in Europe for the Treatment of Metastatic Breast Cancer

author_avatar
NASDAQ Market News

Verona Pharma to Present Expanded Analysis of Phase 2b COPD Data with Ensifentrine at the American Thoracic Society 2021 International Conference

author_avatar
NASDAQ Market News

FIT Biotech Oy: FIT Biotech webcasts the company half-year financial report on September 6th 2018, at 10.00 AM.

FIT Biotech Oy                                                                                               Press Release July 3rd 2018, 10.00 EET FIT Biotech webcasts the ...

author_avatar
NASDAQ Market News